Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program.
A Tichopad, L Pecen, C S Roberts, L Uglesic, G Tesovic, K Rogier
Author Information
- A Tichopad: CEEOR s. r. o., Prague, Czech Republic.
- L Pecen: CEEOR s. r. o., Prague, Czech Republic.
- C S Roberts: Pfizer Inc., New York, NY, USA.
- L Uglesic: Pfizer Croatia d. o. o., Zagreb, Croatia.
- G Tesovic: University of Zagreb Medical School, Zagreb, Croatia.
- K Rogier: Pfizer bv, Capelle a/d IJssel, The Netherlands.
No abstract text available.
